About 19 results found for searched term "Oxytocin Receptor" (0.133 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M29995 | OT-R antagonist 1 | Oxytocin Receptor |
| Oxytocin receptor antagonist 1 | ||
| OT-R antagonist 1 is a new potent and selective nonpeptide low molecular weight OT-R antagonist. OT-R antagonist 1 inhibits oxytocin-evoked intracellular Ca2+ mobilization (IC50 = 8 nM). | ||
| M3777 | Cligosiban | Oxytocin Receptor |
| PF-3274167; PF3274167 | ||
| Cligosiban (PF-3274167) is a high-affinity, high oral bioavailability and good brain-penetrant nonpeptide oxytocin receptor (OTR) antagonist, with Ki of 9.5 nM. | ||
| M5431 | Atosiban Acetate | Vasopressin Receptor |
| RW22164 acetate; RWJ22164 acetate | ||
| Atosiban (RW22164; Tractocile) Acetate is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. | ||
| M5845 | Oxytocin | Animal Modeling |
| α-Hypophamine; Oxytocic hormone | ||
| Oxytocin (α-Hypophamine) is a mammalian neurohypophysial hormone; its actions are mediated by specific, high-affinity oxytocin receptors; ligand of oxytocin receptor.It can be used to construct animal models of primary dysmenorrhea. | ||
| M6879 | L-371,257 | Vasopressin Receptor |
| L-371,257 is a potent and selective oxytocin receptor antagonist. | ||
| M9193 | Carbetocin | Oxytocin Receptor |
| Carbetocin is an oxytocin receptor agonist with a Ki of 7.1 nM. Carbetocin can crosse the blood-brain barrier and produces antidepressant-like activity via activation of oxytocin receptors in the CNS. | ||
| M14040 | L-368,899 hydrochloride | Oxytocin Receptor |
| L-368,899 hydrochloride is a potent, selective, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC50s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively. | ||
| M28530 | L-368,899 | Oxytocin Receptor |
| L-368,899 is an orally active and selective OT (oxytocin ) receptor antagonist, with IC50s of 8.9 and 26 nM for uterus of rat and human, respectively. L-368,899 can cross the blood-brain barrier (BBB). L-368,899 inhibits oxytocin-stimulated uterine contractions in rats and can be used in study of preterm labor. | ||
| M29418 | LIT-001 free base | Oxytocin Receptor |
| LIT-001 free base is the first nonpeptide oxytocin receptor (OT-R) agonist (EC50=55 nM; Ki=226 nM). LIT-001 free base improves social interaction in a mouse model of autism. | ||
| M29419 | LIT-001 | Oxytocin Receptor |
| LIT-001 is the first nonpeptide oxytocin receptor (OT-R) agonist (EC50=55 nM; Ki=226 nM). LIT-001 improves social interaction in a mouse model of autism. | ||
| M30147 | TC OT 39 | Oxytocin Receptor |
| TC OT 39 is a synthetic oxytocin analog, as well as a selective agonist of oxytocin receptor (OXTR, EC50=180 nM). TC OT 39 is also an Avprla vasopressin receptor antagonist with an Ki value of 330 nM. TC OT 39 exhibits sedative effects in mouse models. | ||
| M30776 | Epelsiban | Oxytocin Receptor |
| GSK 557296 | ||
| Epelsiban (GSK 557296) is a potent, selective and orally bioavailable oxytocin receptor antagonist, with a pKi of 9.9 for human oxytocin receptor. | ||
| M30861 | Atosiban | Oxytocin Receptor |
| RW22164; RWJ22164 | ||
| Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research. | ||
| M50228 | Carbetocin acetate | Oxytocin Receptor |
| Carbetocin acetate is an oxytocin (OT) analog and oxytocin receptor agonist that crosses the blood-brain barrier with a Ki of 7.1 nM. In addition, Carbetocin acetate has a high affinity for the chimeric N-terminal (E1) end of the oxytocin receptor, with a Ki = 1.17 μM. Carbetocin acetate can be used in studies related to postpartum hemorrhage. | ||
| M52865 | Val9-Oxytocin | Vasopressin Receptor |
| Val9-Oxytocin is a full antagonist of vasopressin (V1a) receptor. | ||
| M52932 | Barusiban | Oxytocin Receptor |
| Barusiban (FE-200440) is an oxytocin receptor (OT-R) antagonist (Ki=0.8 nM), inhibits OT-induced contraction. | ||
| M52933 | Cargutocin | Oxytocin Receptor |
| Cargutocin, an oxytocin analogue, targets the oxytocin receptor and acts as a uterine contraction agent. | ||
| M52935 | (d(CH2)51, Tyr(Me)2, Thr4, Orn8, des-Gly-NH29)-Vasotocin | Oxytocin Receptor |
| (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin, an oxytocin receptor antagonist, abolishes oxytocin-enhanced inhibitory postsynaptic currents in CA1 pyramidal neurons. | ||
| M52937 | (d(CH2)51, Tyr(Me)2, Orn8)-Oxytocin | Oxytocin Receptor |
| (d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin (OVT) is an oxytocin receptor antagonist. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
